J. Goldman & Co LP Purchases Shares of 595,844 Varex Imaging $VREX

J. Goldman & Co LP purchased a new position in shares of Varex Imaging (NASDAQ:VREX) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 595,844 shares of the company’s stock, valued at approximately $6,215,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Pzena Investment Management LLC acquired a new stake in shares of Varex Imaging in the 2nd quarter valued at approximately $45,312,000. BlackRock Inc. acquired a new position in Varex Imaging during the second quarter worth $40,624,000. Rice Hall James & Associates LLC acquired a new position in Varex Imaging during the second quarter worth $15,080,000. LSV Asset Management increased its holdings in Varex Imaging by 210.7% during the fourth quarter. LSV Asset Management now owns 1,244,329 shares of the company’s stock worth $14,496,000 after buying an additional 843,805 shares during the last quarter. Finally, Millennium Management LLC raised its position in Varex Imaging by 119.8% during the third quarter. Millennium Management LLC now owns 913,169 shares of the company’s stock worth $11,323,000 after acquiring an additional 497,650 shares in the last quarter.

Wall Street Analysts Forecast Growth

VREX has been the subject of a number of recent analyst reports. B. Riley Financial cut shares of Varex Imaging from a “buy” rating to a “hold” rating in a research note on Monday, August 10th. CJS Securities lowered shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a research note on Monday, August 17th. Weiss Ratings raised shares of Varex Imaging from a “sell (d-)” rating to a “sell (d+)” rating in a report on Tuesday, August 11th. Oppenheimer cut Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday, August 10th. Finally, Wall Street Zen raised Varex Imaging from a “hold” rating to a “buy” rating in a research report on Saturday, July 4th. Six research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Varex Imaging has an average rating of “Reduce” and an average price target of $16.88.

Varex Imaging Trading Down 0.1%

VREX stock opened at $18.50 on Wednesday. Varex Imaging has a one year low of $9.09 and a one year high of $18.63. The stock has a market cap of $778.85 million, a price-to-earnings ratio of 35.58 and a beta of 0.89. The company has a fifty day moving average price of $12.70 and a two-hundred day moving average price of $11.89. The company has a debt-to-equity ratio of 0.64, a current ratio of 3.38 and a quick ratio of 1.53.

Varex Imaging (NASDAQ:VREX) last issued its quarterly earnings data on Monday, August 10th. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.10. The company had revenue of $210.50 million for the quarter, compared to analyst estimates of $215.50 million. Varex Imaging had a net margin of 2.55% and a return on equity of 9.19%. Equities analysts anticipate that Varex Imaging will post 0.98 EPS for the current year.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.